WOODCAST: Study on Wood-plastic Composite for Circumferential Casting
Study Details
Study Description
Brief Summary
The purpose of study is to verify that WOODCAST Circular system performs safely and effectively in its intended use.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
An ecologically friendly and biodegradable wood-plastic composite-cast is studied. The purpose of the study is to verify that WOODCAST Circular system performs safely and effectively in its intended use. Patients, who need immobilization of extremity (including for example scaphoid fracture of the wrist or ankle fracture) will be participating in the study. Various casting techniques with novel WOODCAST material will be studied.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: limb casting/splinting Patient age 0-90 years. Patient treatment requires extremity immobilization |
Other: limb casting/splinting
ankle and arm cast
|
Outcome Measures
Primary Outcome Measures
- Efficient Casting With Woodcast Circular System [1 - 6 weeks]
Efficient casting conduc ted with Novel Woodcast material
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patient treatment involves circular casting;
-
age 0-90 years;
-
mother tongue finnish or swedish
Exclusion Criteria:
-
open fracture;
-
other fractures or a previous fracture;
-
a previous or simultaneous tendon-, nerve-, or vascular injury to the extremity yo be treated;
-
a multiple injured extremity;
-
decreased co-operation of the patient;
-
malignancy;
-
an illness affecting the general health.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Helsinki University Hospital | Helsinki | Finland |
Sponsors and Collaborators
- Onbone Oy
Investigators
- Principal Investigator: Nina C Lindfors, MD PhD, Helsinki University Central Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 37/13/03/02/2011
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Limb Casting/Splinting |
---|---|
Arm/Group Description | Patient age 0-90 years. Patient treatment requires extremity immobilization limb casting/splinting: ankle and arm cast |
Period Title: Overall Study | |
STARTED | 97 |
COMPLETED | 97 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Woodcast Circular System Casts |
---|---|
Arm/Group Description | Operatively treated adult patients needing a post-operative Circular Woodcast scaphoid-type cast |
Overall Participants | 97 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
85
87.6%
|
>=65 years |
12
12.4%
|
Sex: Female, Male (Count of Participants) | |
Female |
59
60.8%
|
Male |
38
39.2%
|
Region of Enrollment (participants) [Number] | |
Finland |
97
100%
|
Outcome Measures
Title | Efficient Casting With Woodcast Circular System |
---|---|
Description | Efficient casting conduc ted with Novel Woodcast material |
Time Frame | 1 - 6 weeks |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Limb Casting/Splinting |
---|---|
Arm/Group Description | Patient age 0-90 years. Patient treatment requires extremity immobilization limb casting/splinting: ankle and arm cast |
Measure Participants | 97 |
Number [participants] |
90
92.8%
|
Adverse Events
Time Frame | 1-6 weeks (whole treatment period) | |
---|---|---|
Adverse Event Reporting Description | All Adverse Events were monitored/collected, but none observed. | |
Arm/Group Title | Limb Casting/Splinting | |
Arm/Group Description | Patient age 0-90 years. Patient treatment requires extremity immobilization limb casting/splinting: ankle and arm cast | |
All Cause Mortality |
||
Limb Casting/Splinting | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Limb Casting/Splinting | ||
Affected / at Risk (%) | # Events | |
Total | 0/97 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Limb Casting/Splinting | ||
Affected / at Risk (%) | # Events | |
Total | 0/97 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr Nina Linfors |
---|---|
Organization | Helsinki University Hospital |
Phone | 358 9 4711 |
nina.c.lindfors@hus.fi |
- 37/13/03/02/2011